Clinical trials of the combination of Sputnik V and AstraZeneca vaccines will begin in February 2021
The studies will assess the immunogenicity and safety of combined vaccine usage
The joint research is important in developing an approach to combat future mutations Continue reading
AXON Neuroscience (“Axon”), a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases with a unique peptide vaccine platform, is launching the world’s first independently-developed crowdfunded vaccine against COVID-19 – ACvac1. Read more